Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis: ABROGATE

Study Findings: Study results are pending.

ClinicalTrials.gov ID: NCT02108860

Study Dates: 2015-2023

Disease(s): Granulomatosis with Polyangiitis (GPA)